Melanoma News and Research

Latest Melanoma News and Research

Curcumin has potent anticancer powers

Curcumin, a spice commonly used in curries and other south Asian cooking, blocks a key biological pathway needed for development of melanoma and other cancers, say researchers from the University of Texas M. D. Anderson Cancer Center.

12 Jul 2005

Researchers have pinpointed specific gene and protein over-production in metastatic melanoma

Gene amplification is a process that often happens in cancer cells when the normal DNA replication process is altered, causing many copies of the gene to be produced instead of a single copy of a region of a chromosome.

12 Jul 2005

Sunscreen plays a much more important role than just protecting against sunburn

The number of nevi, or moles, a person has is known to be a strong predictor of the future risk of developing skin cancer, particularly melanoma, the most deadly form of the disease. This number also is believed to be affected by the amount of sun exposure an individual receives.

12 Jul 2005

Good news for curry wallahs, ingredient helps fight cancer

In good news for curry wallahs, researchers are saying that a compound that makes curry yellow could help fight skin cancer.

11 Jul 2005

Researchers have discovered how p16 gene works

University of Minnesota researchers have discovered how a gene that suppresses the development of melanoma and other human cancers works. The study points the way to treatments based on the function of the gene.

11 Jul 2005

Zebrafish provides cancer researchers powerful new insights into the development of malignant melanoma

The embryo of a tiny, silvery tropical fish found in many home aquariums is providing cancer researchers at Northwestern University Feinberg School of Medicine with powerful new insights into the development of malignant melanoma, the deadliest form of skin cancer.

20 Jun 2005

Detection levels of deadly form of melanoma remains the same

Despite campaigns promoting early detection and increased awareness of melanoma (skin cancer) the proportion of the most aggressive and deadly form of melanoma remains the same, according to an article in the June issue of Archives of Dermatology, one of the JAMA/Archives journals.

20 Jun 2005

High exposure to the sun halves risk of prostate cancer

Cancer researchers in the U.S. say that high exposure to the sun halved the risk of prostate cancer in men participating in a U.S. trial.

16 Jun 2005

Exposure to sunlight may decrease the risk of prostate cancer

In the largest such study to date, a research team from three cancer centers measured sunlight exposure in men and found that increased exposure to sunlight may decrease the risk of prostate cancer.

15 Jun 2005

Research urges a new approach to cancer detection

A few years ago, Medhat Osman, M.D., Ph.D., had a patient who was scanned due to a suspicion of lung cancer using positron emission tomography (PET) and computer tomography (CT) technology. The scan came back negative, but the patient then complained of a problem with his leg.

14 Jun 2005

Novel and more effective way of testing which gene mutations cause cancer

Often cancer research goes like this: study cancerous cells in a lab dish, find mutations that appear in many of the samples, develop drugs to target proteins made by the mutated genes, and voila, new chemotherapy drugs are born. Or at least that's the hope.

12 Jun 2005

Bio-engineered skin provides clues to melanoma development

When it comes to the deadly skin cancer melanoma, studying functional tissue rather than cell lines may better provide insight into the disease's development, according to new research from a Howard Hughes Medical Institute predoctoral fellow at Stanford University School of Medicine.

12 Jun 2005

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.

9 Jun 2005

New survey shows Americans falling short on sun protection

Over the past year, the number of Americans using sunscreen, a primary protector against skin cancer, has declined. At the same time, more Americans, including children, are being diagnosed with skin cancer than ever before.

6 Jun 2005

Vaccine targets tumors where they live

Vaccine strategies are being designed to battle cancer, but their use for metastatic melanoma is a challenge.

3 Jun 2005

Having twins reduces the risk of many types of women's cancer

...and starting a family later in life increases risk of breast cancer and melanoma but reduces the risk of ovarian, cervix and uterine cancer according to an international study conducted by a team from The Queensland Institute of Medical Research (QIMR).

1 Jun 2005

New approach to inhibiting blood vessel growth or angiogenesis

A manmade protein with a tail of amino acids delivered to target cells can dramatically reduce blood vessel growth that obstructs vision or feeds a tumor, researchers have found.

31 May 2005

Targepeutics issued new U.S patent

Targepeutics has announced the issuance of U.S. Patent No. 6,884,603 for its genetically modified, mutated Interleukin 13 (IL-13) technology platform for the treatment of malignant glioma, a brain tumor (17,500 people annually; $200 million annual market).

31 May 2005

New understanding of DNA repair processes may pave way to cancer treatments

A Burnham Institute study has found that a protein known for its role in gene regulation has another important function, that of initiating DNA repair. The study, published in the May 27th edition of Molecular Cell, points to new targets for treatment of cancer.

30 May 2005

Whole-body positron emission tomography/computed tomography scans may help physicians identify malignant cancerous tumors

A team of researchers at Johns Hopkins Medical Institutions in Baltimore, Md., reports that whole-body positron emission tomography/computed tomography (PET/CT) scans may help physicians identify new, unexpected malignant cancerous tumors in patients, according to an article in the May issue of the Society of Nuclear Medicine’s Journal of Nuclear Medicine.

29 May 2005